"Fertility Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which increase the capacity to conceive in females.
Descriptor ID |
D005300
|
MeSH Number(s) |
D27.505.696.875.552.344 D27.505.954.705.552.344
|
Concept/Terms |
Fertility Agents, Female- Fertility Agents, Female
- Agents, Female Fertility
- Female Fertility Agents
- Infertility Drugs, Female
- Drugs, Female Infertility
- Female Infertility Drugs
- Infertility Agents, Female
- Agents, Female Infertility
- Female Infertility Agents
|
Below are MeSH descriptors whose meaning is more general than "Fertility Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Fertility Agents, Female".
This graph shows the total number of publications written about "Fertility Agents, Female" by people in this website by year, and whether "Fertility Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 2 | 1 | 3 |
2018 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Fertility Agents, Female" by people in Profiles.
-
Willingness of Women with Endometriosis Planning to Undergo IVF to Participate in a Randomized Clinical Trial and the Effects of the COVID-19 Pandemic on Potential Participation. Reprod Sci. 2022 02; 29(2):620-626.
-
The psychological impact of fertility treatment suspensions during the COVID-19 pandemic. PLoS One. 2020; 15(9):e0239253.
-
A cohort study of both human menopausal gonadotropin (HMG) and recombinant luteinizing hormone addition at early follicular stage in in vitro fertilization outcome: A STROBE-compliant study. Medicine (Baltimore). 2019 May; 98(19):e15512.
-
Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA. J Comp Eff Res. 2019 04; 8(5):337-355.
-
Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs. Eur J Obstet Gynecol Reprod Biol. 2018 Dec; 231:117-121.
-
Heterogeneous hCG and hMG commercial preparations result in different intracellular signalling but induce a similar long-term progesterone response in vitro. Mol Hum Reprod. 2017 10 01; 23(10):685-697.
-
Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database Syst Rev. 2017 Mar 25; 3:CD010931.
-
Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2017 02 23; 2(4):e89703.